If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

  • There is currently no data for ALGW

Acquisition: Completion of ALM Acquisition

30 Jan 2019 07:00

RNS Number : 4508O
Alpha Growth PLC
30 January 2019
 

30 January 2019

Alpha Growth plc

("Alpha", or the "Company")

 

Completion of ALM Acquisition

 

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class announces, further to the Acquisition of ALM RNS release dated 18 July 2018, that the change of control application for Alpha to acquire 100% of the share capital of the regulated entity Alpha Longevity Management Ltd has been approved by the British Virgin Islands Financial Services Commission. Accordingly, all conditions have now been satisfied and the acquisition has now financially closed. 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc

+44 20 3959 8600

Gobind Sahney, Executive Chairman 

info@algwplc.com

VOX Markets (Digital IR)

+44 20 3865 0130

Abraham Darwyne

content@voxmarkets.co.uk

Novum Securities Limited (Corporate Broker)

+44 (0) 207 399 9400

Colin Rowbury

crowbury@novumsecurities.com

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well- established network, Alpha Growth has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Company's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide a wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQPGUWUGUPBGQB
Date   Source Headline
2nd Apr 20257:00 amRNSHolding(s) in Company
2nd Apr 20257:00 amRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNS-RShareholder Update Call
25th Mar 20257:00 amRNSUnaudited Interim 2024 Annual Financial Report
19th Mar 20257:00 amRNSHolding(s) in Company
17th Mar 20253:42 pmRNSIntention to delist from London Stock Exchange
23rd Dec 20244:03 pmRNSNew Accounting Reference Date
12th Dec 202411:03 amRNSNon-Executive Director Appointment
27th Sep 20242:15 pmRNSHolding(s) in Company
17th Sep 20247:00 amRNSHalf-year Report
9th Sep 20247:00 amRNSAcquisition
25th Jun 20249:00 amRNSResult of AGM
6th Jun 20241:44 pmRNSHolding(s) in Company
17th May 20247:00 amRNSAcquisition Insurance Services Company
14th May 20243:39 pmRNSHolding(s) in Company
30th Apr 20241:00 pmRNSAnnual Financial Report
22nd Dec 20239:00 amRNSExpiration of Warrants
13th Dec 20237:00 amRNSAlpha International Life Receives KBRA Rating
14th Nov 20233:36 pmRNSJason Sutherland Receives Industry Recognition
9th Oct 20234:00 pmRNSHolding(s) in Company
9th Oct 20232:43 pmRNSHolding(s) in Company
29th Sep 202311:00 amRNSHalf-year Report
14th Aug 20236:29 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSResult of AGM
6th Jun 20237:00 amRNSNotice of AGM
15th May 20237:00 amRNSAcquisition of Minority Holding and Share Issuance
3rd May 20237:00 amRNSHolding(s) in Company
2nd May 20237:00 amRNS2022 Annual Report & Financial Statements
15th Mar 20237:00 amRNSWarrant Exercise and Total Voting Rights
6th Mar 20237:00 amRNS2022 Annual Recap and Fund Results
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:10 pmRNSHolding(s) in Company
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
20th Jan 202311:05 amRNSSecond Price Monitoring Extn
20th Jan 202311:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSFurther Regarding Havelet Acquisition
6th Dec 20227:00 amRNSCompletion of Share Purchase Acquisition
17th Nov 20227:00 amRNSFinancial Services Company Acquistion
27th Oct 20227:00 amRNSChange of Adviser
26th Oct 20224:41 pmRNSSecond Price Monitoring Extn
26th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20224:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:35 pmRNSPrice Monitoring Extension
3rd Oct 20222:06 pmRNSSecond Price Monitoring Extn
3rd Oct 20222:00 pmRNSPrice Monitoring Extension
3rd Oct 202211:06 amRNSSecond Price Monitoring Extn
3rd Oct 202211:01 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.